{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:28:28Z","timestamp":1774459708160,"version":"3.50.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12016-014-8438-7","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T09:03:43Z","timestamp":1406797423000},"page":"288-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Current Approach to Dry Eye Disease"],"prefix":"10.1007","volume":"49","author":[{"given":"Val\u00e9ria","family":"Valim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia Fernandes Mo\u00e7a","family":"Trevisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline Martins","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f4nica Silva","family":"Vilela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Rubens","family":"Belfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"8438_CR1","doi-asserted-by":"crossref","unstructured":"The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop (2007) Ocul Surf 2007; 5(2): 75\u201392","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"8438_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","volume":"31","author":"MA Lemp","year":"2012","unstructured":"Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD (2012) Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea 31:472\u2013478","journal-title":"Cornea"},{"key":"8438_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1590\/S0004-27492010000200021","volume":"73","author":"EC Fonseca","year":"2010","unstructured":"Fonseca EC, Arruda GV, Rocha EM (2010) Olho seco: etiopatogenia e tratamento\/Dry eye: ethyopathogenesis and treatment. Arq Bras Oftalmol 73:197\u2013203","journal-title":"Arq Bras Oftalmol"},{"key":"8438_CR4","first-page":"178","volume":"19","author":"JB Davies","year":"2008","unstructured":"Davies JB, Prakabar KT (2008) Ocular manifestations of systemic lupus erythematosus. Curr Opin Rheumatol 19:178\u2013181","journal-title":"Curr Opin Rheumatol"},{"key":"8438_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.5114\/aoms.2013.39217","volume":"9","author":"A Waszczykpwaska","year":"2013","unstructured":"Waszczykpwaska A, Gos R, Waszczykpwaska E, Dziankowska-Bartkowiak B, Jurowski P (2013) Prevalence of ocular manifestations in systemic sclerosis patients. Arch Med Sci 9:1107\u20131113","journal-title":"Arch Med Sci"},{"key":"8438_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00004397-199403410-00006","volume":"34","author":"RI Fox","year":"1994","unstructured":"Fox RI (1994) Systemic diseases associated with dry eye. Int Ophtalmol Clin 34:37\u201356","journal-title":"Int Ophtalmol Clin"},{"key":"8438_CR7","first-page":"210","volume":"7","author":"R Fox","year":"2012","unstructured":"Fox R, Creamer P (2012) Clinical manifestations of Sj\u00f6gren\u2019s syndrome: exocrine gland disease. Wolters Kluwer Healt 7:210\u2013235","journal-title":"Wolters Kluwer Healt"},{"key":"8438_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1590\/S0004-27492006000600032","volume":"69","author":"S Felberg","year":"2006","unstructured":"Felberg S, Dantas PEC (2006) Diagn\u00f3stico e tratamento da s\u00edndrome de Sj\u00f5gren\/Sj\u00f6gren\u2019s syndrome: diagnosis and treatment. Arq Bras Oftalmol 69:959\u2013963","journal-title":"Arq Bras Oftalmol"},{"key":"8438_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","volume":"164","author":"SS Kassan","year":"2004","unstructured":"Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sj\u00f6gren\u2019s syndrome. Arch Intern Med 164:1275\u20131284","journal-title":"Arch Intern Med"},{"key":"8438_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/bjophthalmol-2013-303518","volume":"98","author":"SW Landingham Van","year":"2014","unstructured":"Van Landingham SW, West SK, Akpek EK, Mu\u00f1oz B, Ramulu PY (2014) Impact of dry eye on reading in a population based sample of the elderly: the Salisbury Eye Evaluation. Br J Ophthalmol 98:639\u2013644","journal-title":"Br J Ophthalmol"},{"key":"8438_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ajo.2013.12.023","volume":"157","author":"AJ Paulsen","year":"2014","unstructured":"Paulsen AJ, Cruickshanks KJ, Fischer ME, Huang GH, Klein BE, Klein R, Dalton DS (2014) Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol 157:799\u2013806","journal-title":"Am J Ophthalmol"},{"key":"8438_CR12","doi-asserted-by":"crossref","unstructured":"The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop. Ocul Surf 2007; 5: 93\u2013107","DOI":"10.1016\/S1542-0124(12)70082-4"},{"key":"8438_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/archophthalmol.2009.103","volume":"127","author":"DA Schaumberg","year":"2009","unstructured":"Schaumberg DA, Dana R, Buring JE, Sullivan DA (2009) Prevalence of dry eye disease among US Men: estimates from the physicians\u2019 health studies. Arch Ophthalmol 127:763\u2013785","journal-title":"Arch Ophthalmol"},{"key":"8438_CR14","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.ophtha.2013.11.036","volume":"121","author":"A Galor","year":"2014","unstructured":"Galor A, Kumar N, Feuer W, Lee DJ (2014) Environmental factors affect the risk of dry eye syndrome in a United States veteran population. Ophthalmology 121:972\u2013973","journal-title":"Ophthalmology"},{"issue":"2 Suppl","key":"8438_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jtos.2014.02.002","volume":"12","author":"AJ Bron","year":"2014","unstructured":"Bron AJ, Tomlinson A, Foulks GN, Pepose JS, Baudouin C, Geerling G, Nichols KK, Lemp MA (2014) Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf 12(2 Suppl):S1\u2013S31","journal-title":"Ocul Surf"},{"key":"8438_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/978-1-4615-5359-5_113","volume":"438","author":"NL Oden","year":"1998","unstructured":"Oden NL, Lilienfeld DE, Lemp MA, Nelson JD, Ederer F (1998) Sensitivity and specificity of a screening questionnaire for dry eye. Adv Exp Med Biol 438:807\u2013820","journal-title":"Adv Exp Med Biol"},{"key":"8438_CR17","first-page":"1259","volume":"30","author":"SJ Bowman","year":"2003","unstructured":"Bowman SJ, Booth DA, Platts RG, Field A, Rostron J, UK Sj\u00f6gren\u2019s Interest Group (2003) Validation of the sicca symptoms inventory for clinical studies of Sj\u00f6gren\u2019s syndrome. J Rheumatol 30:1259\u20131266","journal-title":"J Rheumatol"},{"key":"8438_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615\u2013621","journal-title":"Arch Ophthalmol"},{"key":"8438_CR19","first-page":"581","volume":"2","author":"MS Zeev","year":"2014","unstructured":"Zeev MS, Miller DD, Latkany R (2014) Diagnosis of dry eye disease and emerging technologies. Clin Ophthalmol 2:581\u2013590","journal-title":"Clin Ophthalmol"},{"key":"8438_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1590\/S0004-27492008000400015","volume":"71","author":"MN Barboza","year":"2008","unstructured":"Barboza MN, Barboza GN, de Melo GM et al (2008) Correlation between signals and symptoms of dry eye in Sj\u00f6gren\u2019s syndrome patients. Arq Bras Oftalmol 71:547\u2013552","journal-title":"Arq Bras Oftalmol"},{"key":"8438_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0008-4182(04)80071-1","volume":"39","author":"FA Adatia","year":"2004","unstructured":"Adatia FA, Michaeli-Cohen A, Naor J, Caffery B, Bookman A, Slomovic A (2004) Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sj\u00f6gren\u2019s syndrome. Can J Ophthalmol 39:767\u2013771","journal-title":"Can J Ophthalmol"},{"key":"8438_CR22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0889-857X(21)00314-8","volume":"18","author":"R Fox","year":"1992","unstructured":"Fox R, Kang HI (1992) Pathogenesis of Sj\u00f6gren\u2019s syndrome. Rheum Dis Clin N Am 18:517\u2013538","journal-title":"Rheum Dis Clin N Am"},{"key":"8438_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF01946264","volume":"56","author":"O Schirmer","year":"2003","unstructured":"Schirmer O (2003) Studien zur physiologie und pathologie der tranen-absonderung und tranenabfuhr. Arch Clin Exp Ophthalmol 56:197\u2013291","journal-title":"Arch Clin Exp Ophthalmol"},{"key":"8438_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.eye.6702204","volume":"21","author":"P Versura","year":"2007","unstructured":"Versura P, Frigato M, Cellini M, Mul\u00e8 R, Malavolta N, Campos EC (2007) Diagnostic performance of tear function tests in Sjogren's syndrome patients. Eye (Lond) 21:229\u2013237","journal-title":"Eye (Lond)"},{"key":"8438_CR25","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1167\/iovs.10-6671","volume":"52","author":"I Monchy de","year":"2011","unstructured":"de Monchy I, Gendron G, Miceli C, Pogorzalek N, Mariette X, Labetoulle M (2011) Combination of the Schirmer I and phenol red thread tests as a rescue strategy for diagnosis of ocular dryness associated with Sj\u00f6gren's syndrome. Invest Ophthalmol Vis Sci 52:5167\u20135173","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8438_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/ard.53.10.637","volume":"53","author":"C Vitali","year":"1994","unstructured":"Vitali C, Moutsopoulos HM, Bombardieri S (1994) The European community study group on diagnostic criteria for Sj\u00f6gren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 53:637\u2013647","journal-title":"Ann Rheum Dis"},{"key":"8438_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00004397-197301310-00008","volume":"13","author":"MA Lemp","year":"1982","unstructured":"Lemp MA (1982) Breakup of the tear film. Int Ophthalmol Clin 13:97\u2013102","journal-title":"Int Ophthalmol Clin"},{"key":"8438_CR28","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1167\/iovs.09-4188","volume":"51","author":"B Caffery","year":"2010","unstructured":"Caffery B, Simpson T, Wang S et al (2010) Rose bengal staining of the temporal conjunctiva differentiates Sj\u00f6gren's syndrome from keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 51:2381\u20132387","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8438_CR29","first-page":"1105","volume":"35","author":"I Knezovi\u0107","year":"2011","unstructured":"Knezovi\u0107 I, Alajbeg I, Karlovi\u0107 D, Pavan J, Vrki\u0107 N, Bis\u0107an A (2011) Differential diagnostic performance of Rose Bengal Score Test in Sj\u00f8gren's syndrome patients. Coll Antropol 35:1105\u20131113","journal-title":"Coll Antropol"},{"key":"8438_CR30","first-page":"113","volume":"40","author":"N Klaassen-Broekema","year":"1992","unstructured":"Klaassen-Broekema N, Mackor AJ, van Bijsterveld OP (1992) The diagnostic power of the tests for tear gland related keratoconjunctivitis sicca. Neth J Med 40:113\u2013116","journal-title":"Neth J Med"},{"key":"8438_CR31","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0161-6420(95)30769-5","volume":"102","author":"FJ Manning","year":"1995","unstructured":"Manning FJ, Wehrly SR, Foulks GN (1995) Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal. Ophthalmology 102:1953\u20131957","journal-title":"Ophthalmology"},{"key":"8438_CR32","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/eye.2011.184","volume":"25","author":"P Hamrah","year":"2011","unstructured":"Hamrah P, Alipour F, Jiang S, Sohn JH, Foulks GN (2011) Optimizing evaluation of Lissamine Green parameters for ocular surface staining. Eye 25:1429\u20131434","journal-title":"Eye"},{"key":"8438_CR33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0161-6420(92)31947-5","volume":"99","author":"RP Feenstra","year":"1992","unstructured":"Feenstra RP, Tseng SC (1992) Comparison of fluorescein and rose bengal staining. Ophthalmology 99:605\u2013617","journal-title":"Ophthalmology"},{"key":"8438_CR34","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1167\/iovs.12-11299","volume":"54","author":"C Begley","year":"2013","unstructured":"Begley C, Simpson T, Liu H et al (2013) Quantitative analysis of tear film fluorescence and discomfort during tear film instability and thinning. Invest Ophthalmol Vis Sci 54:2645\u20132653","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8438_CR35","first-page":"8013","volume":"54","author":"BJ Fenner","year":"2013","unstructured":"Fenner BJ, Tong L (2013) Corneal staining characteristics in limited zones compared with whole cornea documentation for the detection of dry eye subtypes. InvestigOpthalmol Vis Sci 54:8013\u20138019","journal-title":"InvestigOpthalmol Vis Sci"},{"key":"8438_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","volume":"149","author":"JP Whitcher","year":"2010","unstructured":"Whitcher JP, Shiboski CH, Shiboski SC, Sj\u00f6gren's International Collaborative Clinical Alliance Research Groups et al (2010) A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sj\u00f6gren's Syndrome International Registry. Am J Ophthalmol 149:405\u2013415","journal-title":"Am J Ophthalmol"},{"key":"8438_CR37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0161-6420(82)34736-3","volume":"89","author":"KF Tabbara","year":"1982","unstructured":"Tabbara KF, Okumoto M (1982) Ocular ferning test: a qualitative test for mucus deficiency. Ophthalmology 89:712\u2013714","journal-title":"Ophthalmology"},{"key":"8438_CR38","first-page":"541","volume":"6","author":"P Cochet","year":"1961","unstructured":"Cochet P, Bonnet R (1961) Corneal esthesiometry, performance and practical importance. Bull Soc Ophtalmol Fr 6:541\u2013550","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"8438_CR39","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1167\/iovs.04-1426","volume":"46","author":"T Bourcier","year":"2005","unstructured":"Bourcier T, Acosta MC, Borderie V et al (2005) Decreased corneal sensitivity in patients with dry eye. Investig Ophtalmol Vis Sci 46:2341\u20132345","journal-title":"Investig Ophtalmol Vis Sci"},{"key":"8438_CR40","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/bjo.81.11.930","volume":"81","author":"J Dart","year":"1997","unstructured":"Dart J (1997) Impression cytology of the ocular surface: research tool or routine clinical investigation? Br J Ophtalmol 81:930","journal-title":"Br J Ophtalmol"},{"key":"8438_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","volume":"156","author":"SY Lee","year":"2013","unstructured":"Lee SY, Han SJ, Nam SM et al (2013) Analysis of tear cytokines and clinical correlations in Sj\u00f6gren syndrome dry eye patients and non-Sj\u00f6gren syndrome dry eye patients. Am J Ophthalmol 156:247\u2013253","journal-title":"Am J Ophthalmol"},{"key":"8438_CR42","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3109\/02713683.2011.571357","volume":"36","author":"CA Utine","year":"2011","unstructured":"Utine CA, B\u0131\u00e7ak\u00e7\u0131gil M, Yavuz S, \u00c7ift\u00e7i F (2011) Tear osmolarity measurements in dry eye related to primary Sj\u00f6gren's syndrome. Curr Eye Res 36:683\u2013690","journal-title":"Curr Eye Res"},{"key":"8438_CR43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.exer.2013.07.015","volume":"117","author":"N Thun Und Hohenstein-Blaul von","year":"2013","unstructured":"von Thun Und Hohenstein-Blaul N, Funke S, Grus FH (2013) Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res 117:126\u2013137","journal-title":"Exp Eye Res"},{"key":"8438_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ajo.2013.08.025","volume":"157","author":"AJ Kanellopoulos","year":"2014","unstructured":"Kanellopoulos AJ, Asimellis G (2014) In vivo 3-dimensional corneal epithelial thickness mapping as an indicator of dry eye: preliminary clinical assessment. Am J Ophthalmol 157:63\u201368","journal-title":"Am J Ophthalmol"},{"key":"8438_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j. ajo.2014.03.002","author":"GN Foulks","year":"2014","unstructured":"Foulks GN, Pflugfelder SC (2014) New testing options for diagnosing and grading dry eye disease. Am J Ophthalmol. doi: 10.1016\/j. ajo.2014.03.002","journal-title":"Am J Ophthalmol"},{"key":"8438_CR46","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","volume":"25","author":"A Behrens","year":"2006","unstructured":"Behrens A, Doyle JJ, Stern L, Dysfunctional tear syndrome study group et al (2006) Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 25:900\u2013907","journal-title":"Cornea"},{"key":"8438_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304619","author":"C Baudouin","year":"2014","unstructured":"Baudouin C, Aragona P, Van Setten G et al (2014) ODISSEY European consensus group members. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol. doi: 10.1136\/bjophthalmol-2013-304619","journal-title":"Br J Ophthalmol"},{"key":"8438_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jtos.2013.02.002","volume":"11","author":"M Alves","year":"2013","unstructured":"Alves M, Fonseca EC, Alvers MF et al (2013) Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul Surf 11:181\u2013192","journal-title":"Ocul Surf"},{"key":"8438_CR49","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/01.rhu.0000135553.08057.21","volume":"10","author":"AS Papas","year":"2004","unstructured":"Papas AS, Sherrer YS, Charney M et al (2004) Successful treatment of dry mouth and dry eye symptoms in Sj\u00f6gren's syndrome patients with oral pilocarpine: a randomized, placebo-controlled, dose-adjustment study. J Clin Rheumatol 10:169\u2013177","journal-title":"J Clin Rheumatol"},{"key":"8438_CR50","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/art.510","volume":"46","author":"D Petrone","year":"2002","unstructured":"Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P (2002) A double-blind, randomized, placebo-controlled study of cevimeline in Sj\u00f6gren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 46:748\u2013754","journal-title":"Arthritis Rheum"},{"key":"8438_CR51","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","volume":"162","author":"RS Fife","year":"2002","unstructured":"Fife RS, Chase WF, Dore RK (2002) Cevimeline for the treatment of xerostomia in patients with Sj\u00f6gren syndrome: a randomized trial. Arch Intern Med 162:1293\u20131300","journal-title":"Arch Intern Med"},{"key":"8438_CR52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajo.2004.02.010","volume":"138","author":"M Ono","year":"2004","unstructured":"Ono M, Takamura E, Shinozaki K et al (2004) Therapeutic effect of cevimeline on dry eye in patients with Sj\u00f6gren's syndrome: a randomized, double-blind clinical study. Am J Ophthalmol 138:6\u201317","journal-title":"Am J Ophthalmol"},{"key":"8438_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10067-007-0723-x","volume":"27","author":"KC Leung","year":"2008","unstructured":"Leung KC, McMillan AS, Wong MC, Leung WK, Mok MY, Lau CS (2008) The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sj\u00f6gren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study. Clin Rheumatol 27:429\u2013436","journal-title":"Clin Rheumatol"},{"key":"8438_CR54","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1167\/iovs.04-1394","volume":"46","author":"P Aragona","year":"2005","unstructured":"Aragona P, Bucolo C, Spinella R, Giuffrida S, Ferreri G (2005) Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sj\u00f6gren's syndrome patients. Invest Ophthalmol Vis Sci 46:4474\u20134479","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8438_CR55","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1590\/S0004-27492007000400016","volume":"70","author":"MN Pinheiro Jr","year":"2007","unstructured":"Pinheiro MN Jr, dos Santos PM, dos Santos RC, Barros JN, Passos LF, Cardoso Neto J (2007) Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sj\u00f6gren's syndrome patients. Arq Bras Oftalmol 70:649\u2013655","journal-title":"Arq Bras Oftalmol"},{"key":"8438_CR56","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF00541208","volume":"4","author":"R Manthorpe","year":"1984","unstructured":"Manthorpe R, Hagen Petersen S, Prause JU (1984) Primary Sj\u00f6gren's syndrome treated with Efamol\/Efavit. A double-blind cross-over investigation. Rheumatol Int 4:165\u2013167","journal-title":"Rheumatol Int"},{"key":"8438_CR57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/03009748609102073","volume":"15","author":"P Oxholm","year":"1986","unstructured":"Oxholm P, Manthorpe R, Prause JU, Horrobin D (1986) Patients with primary Sj\u00f6gren's syndrome treated for two months with evening primrose oil. Scand J Rheumatol 15:103\u2013108","journal-title":"Scand J Rheumatol"},{"key":"8438_CR58","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/03009740252937577","volume":"31","author":"E Theander","year":"2002","unstructured":"Theander E, Horrobin DF, Jacobsson LT, Manthorpe R (2002) Gammalinolenic acid treatment of fatigue associated with primary Sj\u00f6gren's syndrome. Scand J Rheumatol 31:72\u201379","journal-title":"Scand J Rheumatol"},{"key":"8438_CR59","first-page":"149","volume":"11","author":"PC Fox","year":"1993","unstructured":"Fox PC, Datiles M, Atkinson JC, Macynski AA, Scott J, Fletcher D, Valdez IH, Kurrasch RH, Delapenha R, Jackson W (1993) Prednisone and piroxicam for treatment of primary Sj\u00f6gren's syndrome. Clin Exp Rheumatol 11:149\u2013156","journal-title":"Clin Exp Rheumatol"},{"issue":"4A","key":"8438_CR60","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0002-9343(88)90365-8","volume":"85","author":"RI Fox","year":"1988","unstructured":"Fox RI, Chan E, Benton L, Fong S, Friedlaender M, Howell FV (1988) Treatment of primary Sj\u00f6gren\u2019s syndrome with hydroxychloroquine. Am J Med 85(4A):62\u201367","journal-title":"Am J Med"},{"key":"8438_CR61","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/ard.52.5.360","volume":"52","author":"AA Kruize","year":"1993","unstructured":"Kruize AA, Hen\u00e9 RJ, Kallenberg CG, van Bijsterveld OP, van der Heide A, Kater L, Bijlsma JW (1993) Hydroxychloroquine treatment for primary Sj\u00f6gren's syndrome: a two year double blind crossover trial. Ann Rheum Dis 52:360\u2013364","journal-title":"Ann Rheum Dis"},{"key":"8438_CR62","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00296-010-1415-4","volume":"31","author":"S Yavuz","year":"2011","unstructured":"Yavuz S, Asfuro\u011flu E, Bicakcigil M, Toker E (2011) Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome. Rheumatol Int 31:1045\u20131049","journal-title":"Rheumatol Int"},{"key":"8438_CR63","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/art.20299","volume":"50","author":"V Sankar","year":"2004","unstructured":"Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR (2004) Etanercept in Sj\u00f6gren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum 50:2240\u20132245","journal-title":"Arthritis Rheum"},{"key":"8438_CR64","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/art.20146","volume":"50","author":"X Mariette","year":"2004","unstructured":"Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Pu\u00e9chal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J (2004) Inefficacy of infliximab in primary Sj\u00f6gren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sj\u00f6gren's Syndrome (TRIPSS). Arthritis Rheum 50:1270\u20131276","journal-title":"Arthritis Rheum"},{"key":"8438_CR65","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/art.27314","volume":"62","author":"JM Meijer","year":"2010","unstructured":"Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H (2010) Effectiveness of rituximab treatment in primary Sj\u00f6gren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 62:960\u2013968","journal-title":"Arthritis Rheum"},{"key":"8438_CR66","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/art.27509","volume":"62","author":"V Devauchelle-Pensec","year":"2010","unstructured":"Devauchelle-Pensec V, Cagnard N, Pers JO, Youinou P, Saraux A, Chiocchia G (2010) Gene expression profile in the salivary glands of primary Sj\u00f6gren's syndrome patients before and after treatment with rituximab. Arthritis Rheum 62:2262\u20132271","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8438_CR67","doi-asserted-by":"publisher","first-page":"R172","DOI":"10.1186\/ar4359","volume":"15","author":"F Carubbi","year":"2013","unstructured":"Carubbi F, Cipriani P, Marrelli A, Benedetto P, Ruscitti P, Berardicurti O, Pantano I, Liakouli V, Alvaro S, Alunno A, Manzo A, Ciccia F, Gerli R, Triolo G, Giacomelli R (2013) Efficacy and safety of rituximab treatment in early primary Sj\u00f6gren's syndrome: a prospective, multi-center, follow-up study. Arthritis Res Ther 15(5):R172","journal-title":"Arthritis Res Ther"},{"key":"8438_CR68","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/ICO.0b013e3181e9adcc","volume":"30","author":"JH Lee","year":"2011","unstructured":"Lee JH, Ahn HS, Kim EK, Kim TI (2011) Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease. Cornea 30:175\u2013179","journal-title":"Cornea"},{"key":"8438_CR69","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/jop.2008.0026","volume":"25","author":"M Rolando","year":"2009","unstructured":"Rolando M, Autori S, Badino F, Barabino S (2009) Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J Ocular Pharmacol Ther 25:271\u2013278","journal-title":"J Ocular Pharmacol Ther"},{"key":"8438_CR70","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00417-004-1040-6","volume":"243","author":"F Brignole","year":"2005","unstructured":"Brignole F, Pisella PJ, Dupas B et al (2005) Efficacy and safety of 0.18\u00a0% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol 243:531\u2013538","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"8438_CR71","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/bjo.86.2.181","volume":"86","author":"P Aragona","year":"2002","unstructured":"Aragona P, Papa V, Micali A et al (2002) Long-term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 86:181\u2013184","journal-title":"Br J Ophthalmol"},{"key":"8438_CR72","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jcrs.2005.10.034","volume":"32","author":"GM Salib","year":"2006","unstructured":"Salib GM, McDonald MB, Smolek M (2006) Safety and efficacy of cyclosporine 0.05\u00a0% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis. J Cataract Refract Surg 32:772\u2013778","journal-title":"J Cataract Refract Surg"},{"key":"8438_CR73","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","volume":"107","author":"K Sall","year":"2000","unstructured":"Sall K, Stevenson OD, Mundorf TK, Reis BL (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107:631\u2013639","journal-title":"Ophthalmology"},{"key":"8438_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.icl.0000170599.57728.29","volume":"32","author":"KN Sall","year":"2006","unstructured":"Sall KN, Cohen SM, Dhristensen MT, Stein JM (2006) An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with market artificial tears as supportive therapy in dry eye disease. Eye Contact Lens 32:21\u201326","journal-title":"Eye Contact Lens"},{"key":"8438_CR75","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1755-3768.1994.tb02792.x","volume":"72","author":"K Gunduz","year":"1994","unstructured":"Gunduz K, Ozdemir O (1994) Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren\u2019s syndrome. Acta Ophthalmol (Copenh) 72:438\u2013442","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"8438_CR76","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jama.2010.1014","volume":"28","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals M, Tzioufas AG, Stone JH, Sis\u00f3 A, Bosch X (2010) Treatment of primary Sj\u00f6gren syndrome: a systematic review. JAMA 28:452\u2013460","journal-title":"JAMA"},{"key":"8438_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1100\/2012\/194848","volume":"24","author":"B Yavuz","year":"2012","unstructured":"Yavuz B, Bozda\u011f Pehlivan S, Unl\u00fc N (2012) An overview on dry eye treatment: approaches for cyclosporin a delivery. Sci World J 24:1\u201311","journal-title":"Sci World J"},{"key":"8438_CR78","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5301\/ejo.5000229","volume":"23","author":"P Aragona","year":"2013","unstructured":"Aragona P, Spinella R, Rania L et al (2013) Safety and efficacy of 0.1\u00a0% clobetasone butyrate eyedrops in the treatment of dry eye in Sj\u00f6gren syndrome. Eur J Ophthalmol 23:368\u2013376","journal-title":"Eur J Ophthalmol"},{"key":"8438_CR79","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3349\/ymj.2014.55.1.203","volume":"55","author":"JH Lee","year":"2014","unstructured":"Lee JH, Min K, Kim SK, Kim EK, Kim TI (2014) Inflammatory cytokine and osmolarity changes in the tears of dry eye patients treated with topical 1\u00a0% methylprednisolone. Yonsei Med J 55:203\u2013208","journal-title":"Yonsei Med J"},{"key":"8438_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1475-1313.2003.00081.x","volume":"23","author":"J Farrell","year":"2003","unstructured":"Farrell J, Patel S, Grierson DG, Sturrock RD (2003) A clinical procedure to predict the value of temporary occlusion therapy in keratoconjunctivitis sicca. Ophthalmic Physiol Opt 23:1\u20138","journal-title":"Ophthalmic Physiol Opt"},{"key":"8438_CR81","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s00296-013-2769-1","volume":"33","author":"W Qiu","year":"2013","unstructured":"Qiu W, Liu Z, Ao M, Li X, Wang W (2013) Punctal plugs versus artificial tears for treating primary Sj\u00f6gren's syndrome with keratoconjunctivitis SICCA: a comparative observation of their effects on visual function. Rheumatol Int 33:2543\u20132548","journal-title":"Rheumatol Int"},{"key":"8438_CR82","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1755-3768.2009.01855.x","volume":"89","author":"MS Lee","year":"2011","unstructured":"Lee MS, Shin BC, Choi TY, Ernst E (2011) Acupuncture for treating dry eye: a systematic review. Acta Ophthalmol 89:101\u2013106","journal-title":"Acta Ophthalmol"},{"key":"8438_CR83","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/art.1780270415","volume":"27","author":"RI Fox","year":"1984","unstructured":"Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE (1984) Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 27:459\u2013461","journal-title":"Arthritis Rheum"},{"issue":"6 Supl","key":"8438_CR84","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1590\/S0004-27492008000700010","volume":"71","author":"GG Quinto","year":"2008","unstructured":"Quinto GG, Campos M, Behrens A (2008) Autologous serum for ocular surface diseases. Arq Bras Oftalmol 71(6 Supl):47\u201354","journal-title":"Arq Bras Oftalmol"},{"key":"8438_CR85","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00417-004-1106-5","volume":"243","author":"L Liu","year":"2005","unstructured":"Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G (2005) An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 243:706\u2013714","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"8438_CR86","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S1542-0124(12)70165-9","volume":"4","author":"BH Koffler","year":"2006","unstructured":"Koffler BH (2006) Autologous serum therapy of the ocular surface with novel delivery by platelet concentrate gel. Ocul Surf 4:188\u2013195","journal-title":"Ocul Surf"},{"key":"8438_CR87","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/bjo.85.10.1188","volume":"85","author":"AC Poon","year":"2001","unstructured":"Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT (2001) Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 85:1188\u20131197","journal-title":"Br J Ophthalmol"},{"key":"8438_CR88","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1442-9071.2008.01680.x","volume":"36","author":"GA Lee","year":"2008","unstructured":"Lee GA, Chen SX (2008) Autologous serum in the management of recalcitrant dry eye syndrome. Clin Exp Ophthalmol 36:119\u2013122","journal-title":"Clin Exp Ophthalmol"},{"key":"8438_CR89","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","volume":"139","author":"T Kojima","year":"2005","unstructured":"Kojima T, Ishida R, Dogru M et al (2005) The effect of autologous serum eye drops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 139:242\u2013246","journal-title":"Am J Ophthalmol"},{"key":"8438_CR90","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/00003226-200111000-00005","volume":"20","author":"N Tananuvat","year":"2001","unstructured":"Tananuvat N, Daniell M, Sullivan LJ et al (2001) Controlled study of the use of autologous serum in dry eye patients. Cornea 20:802\u2013806","journal-title":"Cornea"},{"key":"8438_CR91","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1001\/archopht.1988.01060140587028","volume":"106","author":"PJ McDonnell","year":"1988","unstructured":"McDonnell PJ, Schanzlin DJ, Rao NA (1988) Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol 106:1423\u20131425","journal-title":"Arch Ophthalmol"},{"key":"8438_CR92","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/00006534-200009010-00034","volume":"106","author":"GJ Rosenberg","year":"2000","unstructured":"Rosenberg GJ (2000) Temporary tarsorrhaphy suture to prevent or treat scleral show and ectropion secondary to laser resurfacing or laser blepharoplasty. Plast Reconstr Surg 106:721\u2013725","journal-title":"Plast Reconstr Surg"},{"key":"8438_CR93","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/00003226-200111000-00002","volume":"20","author":"CB Cosar","year":"2001","unstructured":"Cosar CB, Cohen EJ, Rapuano CJ et al (2001) Tarsorrhaphy: clinical experience from a cornea practice. Cornea 20:787\u2013791","journal-title":"Cornea"},{"key":"8438_CR94","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/eye.2011.75","volume":"25","author":"A Kheirkhah","year":"2011","unstructured":"Kheirkhah A, Zavareh MK, Farzbod F, Mahbod M, Behrouz MJ (2011) Topical 0.005\u00a0% tacrolimus eye drop for refractory vernal keratoconjunctivitis. Eye (Lond) 25:872\u2013880","journal-title":"Eye (Lond)"},{"key":"8438_CR95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ophtha.2012.03.017","volume":"119","author":"JF Huang","year":"2012","unstructured":"Huang JF, Yafawi R, Zhang M et al (2012) Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease. Ophthalmology 119:43\u201350","journal-title":"Ophthalmology"},{"key":"8438_CR96","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ajo.2012.01.034","volume":"154","author":"A Okanobo","year":"2012","unstructured":"Okanobo A, Chauhan SK, Dastjerdi MH, Kodati S, Dana R (2012) Efficacy of topical blockade of interleukin-1 in experimental dry eye disease. Am J Ophthalmol 154:63\u201371","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"8438_CR97","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","volume":"73","author":"PM Meiners","year":"2014","unstructured":"Meiners PM, Vissink A, Kroese FG, Spijkervet FK, Smitt-Kamminga NS, Abdulahad WH, Bulthuis-Kuiper J, Brouwer E, Arends S, Bootsma H (2014) Abatacept treatment reduces disease activity in early primary Sjogren's syndrome (open-label proof of concept ASAP study). Ann Rheum Dis 73(7):1393\u20131396","journal-title":"Ann Rheum Dis"},{"key":"8438_CR98","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/acr.22052","volume":"65","author":"S Adler","year":"2013","unstructured":"Adler S, K\u00f6rner M, F\u00f6rger F, Huscher D, Caversaccio MD, Villiger PM (2013) Evaluation of histological, serological and clinical changes in response to abatacept treatment of primary Sj\u00f6gren's syndrome: a pilot study. Arthritis Care Res (Hoboken) 65:1862\u20131868","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8438_CR99","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203991","author":"X Mariette","year":"2013","unstructured":"Mariette X, Seror R, Quartuccio L, Baron G, Salvin S, Fabris M, Desmoulins F, Nocturne G, Ravaud P, De Vita S (2013) Efficacy and safety of belimumab in primary Sjogren\u2019s syndrome: results of the BELISS open-label phase II study. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-203991","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-014-8438-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-014-8438-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-014-8438-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-014-8438-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T06:40:06Z","timestamp":1649832006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-014-8438-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["8438"],"URL":"https:\/\/doi.org\/10.1007\/s12016-014-8438-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,1]]},"assertion":[{"value":"1 August 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}